Mergers & Acquisitions

  • May 23, 2025

    Squire Patton, Kirkland Lead Goodyear's $650M PE Deal

    Goodyear Tire, represented by Squire Patton Boggs LLP, has agreed to sell a majority of its chemical business to Gemspring Capital, a private equity shop advised by Kirkland & Ellis LLP, in a $650 million transaction that followed a strategic review of the subsidiary.

  • May 23, 2025

    Taxation With Representation: Troutman, A&O Shearman

    In this week's Taxation With Representation, Blackstone acquires TXNM Energy, OpenAI buys io Products, Lumen Technologies sells its Mass Markets fiber-to-the-home business in 11 states to AT&T, and AMD sells its data center infrastructure manufacturing business to Sanmina.

  • May 23, 2025

    Kilpatrick Grows M&A And Venture Capital Teams

    Kilpatrick Townsend & Stockton LLP has added an experienced attorney to its corporate practice and its mergers and acquisitions and venture capital teams.

  • May 23, 2025

    FTC Finally Drops Challenge To Microsoft-Activision Deal

    The Federal Trade Commission has dropped its in-house case seeking to block Microsoft's $68.7 billion purchase of video game developer Activision Blizzard, after its Ninth Circuit loss earlier this month, ending a lingering challenge to a deal that closed in late 2023.

  • May 23, 2025

    Torys-Led Vermilion Sells Canadian Gas Assets For CA$415M

    Global gas producer Vermilion Energy Inc., advised by Torys LLP, on Friday announced plans to sell its Saskatchewan and Manitoba assets in Canada for CA$415 million ($301.04 million).

  • May 23, 2025

    Assura Tells Shareholders Not To Vote On KKR, Stonepeak Bid

    The board of property manager Assura told shareholders on Friday not to vote for a £1.6 billion ($2.2 billion) offer from U.S. private equity firms KKR and Stonepeak as it assesses a rival bid of £1.7 billion.

  • May 23, 2025

    International Paper Co. To Shut 5 Sites After DS Smith Deal

    International Paper Co. confirmed on Friday that plans including a move to shut down five of its packaging sites in Britain will go ahead, warning that the closures could affect 300 jobs following its acquisition of packaging provider DS Smith PLC.

  • May 23, 2025

    RedBird To Buy Telegraph As Gov't Relaxes Ownership Rules

    Investment firm RedBird Capital Partners said Friday that it will buy the Telegraph Media Group in a £500 million ($675 million) transaction that hands a minority stake in the publisher to its Abu Dhabi-backed subsidiary after the government floated plans to loosen foreign-ownership rules for British newspapers.

  • May 22, 2025

    Lottery.com Execs Cop To Securities Fraud In SPAC Case

    Two former Lottery.com executives pled guilty Thursday to their role in a scheme to fraudulently inflate reported revenues in a 2021 take-public deal involving the mobile and online lottery gaming platform company.

  • May 22, 2025

    Proxy Proposal Omissions Rose Post-SEC Bulletin, Study Finds

    There was a sharp drop in the total number of shareholder proxy proposals submitted this year and a rise in the number of submitted proposals that were omitted from corporate ballots following the U.S. Securities and Exchange Commission's rescission of past guidance, ISS Corporate Solutions Inc. said Thursday.

  • May 22, 2025

    Firm Drops $500K Contract Suit Against Cannabis POS Co.

    A federal judge in Seattle dismissed a breach of contract suit between cannabis payment tech companies over a final $500,000 payment in a deal to buy a rival.

  • May 22, 2025

    Cities Say They Fixed Bid To Divest Axon Police Camera Buy

    A trio of local governments urged a New Jersey federal judge Wednesday not to tee up an attack on their bid to force Axon Enterprise Inc. to divest a police body camera company whose purchase they say helped it monopolize the market, arguing they've fixed failings from an earlier complaint.

  • May 22, 2025

    Senators Unveil DNA Privacy Bill Amid 23andMe's Ch. 11 Sale

    A bipartisan group of U.S. senators on Thursday introduced a bill designed to safeguard customers' genetic information in bankruptcy cases, saying 23andMe's plan to sell users' DNA data to a pharmaceutical company during its Chapter 11 raises new concerns surrounding consumer privacy.

  • May 22, 2025

    Motorola Eyes $4.5B Wireless Radio Deal, And Other Rumors

    Motorola eyes a $4.5 billion purchase of a wireless radio maker, Providence Equity buys a live event company at a reported $1 billion value and Intel's sale of a networking unit could attract billions. Here, Law360 breaks down these and other notable deal-related rumors from the past week.

  • May 22, 2025

    Oyster Enterprises II SPAC Prices $220M IPO

    Special purpose acquisition company Oyster Enterprises II Acquisition Corp. began trading publicly on Thursday following its $220 million initial public offering.

  • May 22, 2025

    Millicom Buying Telefonica's Uruguay Mobile Unit For $440M

    Millicom International Cellular has agreed to acquire Telefonica's mobile operations in Uruguay at a $440 million enterprise value, in a deal that will expand its Latin America footprint through one of the region's most stable economies.

  • May 22, 2025

    Gem Group Plugs $100M Into MoviePass For Fantasy Platform

    A fund sponsored by alternative investment firm Gem Group announced Thursday that it completed its inaugural investment in MoviePass, plugging $100 million into the company that says it is "redefining" the moviegoing experience.

  • May 22, 2025

    Senior FCC Democrat Attends Final Monthly Meeting

    Geoffrey Starks, the senior Democrat on the Federal Communications Commission, participated in his last agency meeting Thursday, where he announced he will leave the agency sometime within the next month.

  • May 22, 2025

    Cleary Closes Frankfurt Office As It Consolidates In Germany

    Cleary is closing its office in Frankfurt after more than three decades as the U.S. law firm consolidates its operations in Germany under one location.

  • May 22, 2025

    Sanofi To Acquire Goodwin-Led US Biotech Biz For $470M

    Drugmaker Sanofi said Thursday that it has agreed to acquire Vigil Neuroscience, a biotechnology company specializing in neurodegenerative diseases, for approximately $470 million to give it a potential new medicine for Alzheimer's disease in a deal guided by Goodwin Procter.

  • May 22, 2025

    Latham Leads Honeywell In £1.8B UK Catalyst Tech Biz Buy

    Honeywell International Inc. said Thursday it has agreed to acquire the catalyst technologies arm of Johnson Matthey PLC, a U.K. chemicals company, for £1.8 billion ($2.4 billion), as the U.S. technology conglomerate moves to broaden its refining and renewable fuel portfolio.

  • May 21, 2025

    Discover Interim Legal Chief Exits As Capital One Deal Closes

    Discover Financial Services' interim chief legal officer and general counsel departed on Sunday, the same day Capital One Financial Corp. finalized its $35 billion acquisition of the financial services company.

  • May 21, 2025

    House Panel Advances Bills Easing Securities, Banking Regs

    The U.S. House of Representatives Financial Services Committee this week approved 25 bills largely aimed at reducing capital markets and banking regulations, moving the deregulatory proposals forward for consideration by the full House.

  • May 21, 2025

    Verizon Looks To Break Free Of TracFone Unlocking Condition

    Verizon is once again asking the Federal Communications Commission to let it out of a condition from its takeover of TracFone requiring the carrier to unlock its mobile phones after 60 days.

  • May 21, 2025

    Latham, Gibson Dunn Steer $5.75B Lumen, AT&T Fiber Deal

    Lumen Technologies, represented by Latham & Watkins, announced Wednesday that it is selling its Mass Markets fiber-to-the-home business in 11 states to AT&T Inc., represented by Gibson Dunn & Crutcher LLP, in a $5.75 billion cash deal that is expected to close in the first half of 2026.

Expert Analysis

  • Predictions For Trump Antitrust Enforcement Of Life Sciences

    Author Photo

    Key life sciences antitrust issues of the past two administrations may indicate the direction of enforcement during President-elect Donald Trump's second term, including in areas such as drug prices, killer acquisitions and merger remedies, say attorneys at Ropes & Gray.

  • Firms Still Have The Edge In Lateral Hiring, But Buyer Beware

    Author Photo

    Partner mobility data suggests that the third quarter of this year continued to be a buyer’s market, with the average candidate demanding less compensation for a larger book of business — but moving into the fourth quarter, firms should slow down their hiring process to minimize risks, say officers at Decipher Investigative Intelligence.

  • Preparing For The New Restrictions On Investment Into China

    Author Photo

    In light of a new regulatory program governing U.S. investments in China-related technology companies of national security concern, investors should keep several considerations in mind, including the rules' effect on existing and new investments, compliance hurdles, and penalties for noncompliance ahead of the rules' January implementation, say attorneys at Gunderson Dettmer.

  • Lights, Camera, Real Estate: Preparing For Film Facility M&A

    Author Photo

    As the entertainment industry struggles to recover from multiple strikes and a decline in production, certain aspects of selling or acquiring production facilities may become important to consider, as these assets are valued very differently from typical commercial real estate properties, say attorneys at Olshan Frome.

  • Think Like A Lawyer: 1 Type Of Case Complexity Stands Out

    Author Photo

    In contrast to some cases that appear complex due to voluminous evidence or esoteric subject matter, a different kind of complexity involves tangled legal and factual questions, each with a range of possible outcomes, which require a “sliding scale” approach instead of syllogistic reasoning, says Luke Andrews at Poole Huffman.

  • Back To The Future? Antitrust Enforcement Under Trump 2.0

    Author Photo

    While the transition to the second Trump administration's antitrust policy should be accompanied by less uncertainty, we're unlikely to get a full sense of the true focus and tenor of competition enforcement under Trump 2.0 before late next year, say attorneys at Simpson Thacher.

  • Think Like A Lawyer: Note 3 Simple Types Of Legal Complexity

    Author Photo

    Cases can appear complex for several reasons — due to the number of issues, the volume of factual and evidentiary sources, and the sophistication of those sources — but the same basic technique can help lawyers tame their arguments into a simple and persuasive message, says Luke Andrews at Poole Huffman.

  • Antitrust in Retail: Handbag Ruling Won't Go Out Of Fashion

    Author Photo

    Although a New York federal court’s recent decision to enjoin a proposed $8.5 billion merger between the owners of Michael Kors and Coach applied noncontroversial antitrust interpretations, several notable aspects of the opinion stand out as likely candidates for further discussion in future merger litigation, say attorneys at Holland & Knight.

  • Series

    Gardening Makes Me A Better Lawyer

    Author Photo

    Beyond its practical and therapeutic benefits, gardening has bolstered important attributes that also apply to my litigation practice, including persistence, patience, grit and authenticity, says Christopher Viceconte at Gibbons.

  • Takeaways From DOJ's Intervention On Pricing Algorithm Use

    Author Photo

    A recent U.S. Justice Department amicus brief arguing that a Nevada federal judge wrongly focused on the nonbinding aspect of software company Cendyn Group's pricing algorithm underscores the growing challenge of determining when, if ever, pricing algorithms are legal, say attorneys at Rule Garza.

  • Equitable Mootness Insights From Greenlit Ch. 11 Plan Appeal

    Author Photo

    A Texas federal court recently allowed a challenge to ConvergeOne's Chapter 11 bankruptcy plan to proceed because it wouldn't disrupt the IT company's confirmed plan or harm creditors, reinforcing the importance of judicial restraint in applying equitable mootness where limited relief is possible, say attorneys at Parkins & Rubio.

  • Litigation Inspiration: Reframing Document Review

    Author Photo

    For attorneys — new ones especially — there is much fulfillment to find in document review by reflecting on how important, interesting and pleasant it can be, says Bennett Rawicki at Hilgers Graben.

  • Expect More State Scrutiny Of PE In Healthcare M&A

    Author Photo

    While a California bill that called for increased antitrust scrutiny of many healthcare private equity transactions was recently vetoed by the governor, state legislatures are likely to continue introducing similar laws, particularly if the Trump administration eases federal enforcement, say attorneys at Morgan Lewis.

  • 3 Changes Community Banks Should Expect Under Trump

    Author Photo

    A second Trump administration promises a sea change for regional and community banks, including shifts in the regulatory environment, Community Reinvestment Act rules and the M&A landscape, say attorneys at Manatt.

  • How CFIUS' Updated Framework Affects Global Investors

    Author Photo

    The recent change to the monitoring and enforcement regulations governing the Committee on Foreign Investment in the United States will broaden administrative practices around nonnotified transaction investigations, increase the scope of information demands from the committee and accelerate its ability to impose mitigation on parties, say attorneys at Simpson Thacher.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.